Table 3 Characteristics associated with overall, bladder cancer-specific, and recurrence-free survival, by postoperative medication

Postoperative medication use

- Statins

0.90

(0.80–1.01)

0.76

(0.63–0.91)

0.79

(0.69–0.91)

0.65

(0.53–0.81)

0.82

(0.72–0.93)

0.69

(0.56–0.84)

- NSAIDs

1.14

(1.00-1.30)

1.34

(1.11–1.61)

1.08

(0.92–1.27)

1.46

(1.18–1.82)

1.12

(0.96–1.30)

1.47

(1.20–1.80)

   - Aspirin

1.16

(1.03–1.30)

1.16

(0.96–1.41)

0.98

(0.85–1.14)

1.18

(0.94–1.48)

0.91

(0.80–1.04)

1.05

(0.85–1.30)

   - Other NSAIDs

1.13

(0.99–1.29)

1.25

(1.05–1.49)

1.24

(1.06–1.46)

1.49

(1.22–1.82)

1.40

(1.21–1.63)

1.55

(1.29–1.87)

- Metformin

1.16

(0.98–1.38)

1.18

(0.93–1.50)

1.19

(0.97–1.46)

1.32

(0.99–1.75)

1.25

(1.04–1.51)

1.31

(1.01–1.70)

- Prednisone

1.07

(0.92–1.23)

0.85

(0.70–1.03)

0.93

(0.77–1.11)

0.87

(0.69–1.09)

0.96

(0.81–1.13)

0.87

(0.71–1.08)